Research comparison
MOTS-c vs SS-31
Side-by-side comparison of research status, mechanisms, pharmacokinetics, and administration routes.
Research Status
Preclinical
Phase II
Half-Life
Short; exercise significantly elevates circulating MOTS-c
~2 hours; mitochondrial targeting is rapid
Mol. Weight
—
—
Admin Routes
subcutaneous, intravenous
subcutaneous, intravenous
Categories
Mitochondrial Health, Fat Loss & Metabolic, Anti-Aging & Longevity
Mitochondrial Health, Cardiovascular, Anti-Aging & Longevity
Interaction
synergistic
MOTS-c drives mitochondrial biogenesis and metabolic reprogramming via AMPK, while SS-31 directly protects the inner mitochondrial membrane from oxidative stress — together they may offer complementary mitochondrial support.
emerging
Mechanism
Pharmacokinetics
Research Findings
Safety
Related comparisons